BANGKOK, Thailand—Results from Hoya Vision Care's Early Experience Program (EEP) research program showed that patients could wear MiyoSmart sun solution Chameleon lenses an average of 12 hours per day during weekdays, and did not need to switch lenses when spending time outdoors, according to an announcement from the company. The company noted that the extended wear time translates to a longer treatment duration, maximizing the effectiveness of myopia management in children. The research also found that almost 80 percent of wearers adapted to the lens within one day, Hoya said.

“The results of our Early Experience Program, showing great adaptation, tolerability and overall satisfaction in patients of different ages and ethnicities, is testament to Hoya’s research and commitment to providing innovative solutions,” said Marianne Goldwaser, professional affairs manager at Hoya Vision Care.

Released in 2023, MiyoSmart photochromic lenses are designed to provide an all-in-one solution to myopia management and protected outdoor activity by rapidly adapting to the level of sunlight, fading back to clear while indoors in seconds, according to Hoya.

Hoya said the goal of the Early Experience Program was to evaluate the acceptance of MiyoSmart Chameleon spectacle lenses, as well as gain insights into the wearers’ habits. Teenagers adapted to the new lenses as quickly as younger children. All of the program’s Chameleon spectacle wearers, both new and experienced, reported being satisfied with the visual performance during outdoor and indoor activities, and were comfortable with the fade-back-to-clear feature, regardless of geographic location.

The EEP research also revealed that wearing MiyoSmart Chameleon lenses for two weeks significantly reduced light sensitivity in patients receiving concurrent low-dose atropine treatment, at a rate of 22 percent baseline and 50 percent after two weeks of wear.

The research was compiled through the collection and analysis of data from 100 patients, aged 3 to 20 years old, located across Europe, Asia, Australia and New Zealand.

Hoya Vision Care said the research data will be shared with eyecare professionals and parents to answer questions about the MiyoSmart sun range and gain insights into patients’ behaviors while wearing the product.

MiyoSmart has not been approved for myopia management in all countries, including the U.S., and is not currently available for sale in all countries, including the U.S., according to Hoya.